Cited by 20Diabetes, Cardiovascular Risks, and LipoproteinsPancreatic function and diabetesAdipokines, Inflammation, and Metabolic Diseases

Arterial Norepinephrine Concentration is Inversely and Independently Associated With Insulin Clearance in Obese Individuals With Metabolic Syndrome

Open access
Straznicky, Nora E., Grima, Mariee T., Lambert, Elisabeth A., Sari, Carolina I., Eikelis, Nina, Nestel, Paul J., Phillips, Sarah E., Hering, Dagmara +4 more·2015·The Journal of Clinical Endocrinology & Metabolism

Abstract

CONTEXT: Impaired insulin clearance contributes to the hyperinsulinemia of obesity, yet relatively little is known concerning the pathophysiological determinants of insulin clearance in obese populations. OBJECTIVE: To examine the cross-sectional relationship between insulin clearance and resting sympathetic nervous system activity in a cohort of obese subjects with metabolic syndrome. PARTICIPANTS AND METHODS: Unmedicated, nonsmoking subjects (31 male, 27 female; aged 56 ± 1 year; body mass index 33.7 ± 0.6 kg/m(2)) underwent euglycemic hyperinsulinemic clamp to determine insulin sensitivity (M) and insulin clearance, assessment of norepinephrine kinetics, peripheral arterial tonometry, Doppler echocardiography, and oral glucose tolerance test. RESULTS: Univariate correlation analyses showed inverse associations between insulin clearance and arterial norepinephrine concentration (r = -0.44, P = .0006), calculated norepinephrine spillover rate (r = -0.33, P = .01), augmentation index (AI, r = -0.37, P = .005), and positive associations with M (r = 0.30, P = .02), Matsuda insulin sensitivity index (r = 0.27, P = .04), and cardiac output (r = 0.27, P = .04). Insulin clearance and sensitivity did not differ between genders, however females had higher AI compared to males (35 ± 3% versus 14 ± 2%, P < .001). In age and gender adjusted stepwise regression analyses, arterial norepinephrine concentration alone explained 19% of the variance in insulin clearance. When all significant variables were entered into the regression model, arterial norepinephrine, AI, gender, and M were independent predictors of insulin clearance, together explaining 41% of the variance. CONCLUSIONS: Arterial norepinephrine concentration is inversely and independently associated with whole-body insulin clearance rate in obese individuals with metabolic syndrome. Prospective studies are needed to determine the direction of causality and the chronology of interactions between insulin clearance and sympathetic neural activity.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2014-3796

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The difference in insulin clearance was similar and significant regardless of adjustment for endogenous insulin secretion.

    “This difference was similar and significant regardless of adjustment for endogenous insulin secretion (15), and the adjusted value is presented.”

    From Primary aldosteronism decreases insulin secretion and increases insulin clearance in humans (2020) · cites this paper as [15]

    The Glucose metabolism and insulin clearance section (page unavailable) describes calculating insulin clearance with a correction for residual endogenous insulin secretion. The Discussion (page unavailable) reports a significant association involving insulin clearance, but the paper does not compare adjusted and unadjusted results or establish that a difference remained similar and significant under both calculations. (LLM, conf=0.78)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Straznicky, N. E., Grima, M. T., Lambert, E. A., Sari, C. I., Eikelis, N., Nestel, P. J., Phillips, S. E., Hering, D., Karapanagiotidis, S., Dixon, J. B., Schlaich, M. P., & Lambert, G. W.
Affiliations
Baker Heart and Diabetes Institute (AU)
Corresponding author
Straznicky, Nora E.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2015-04
Volume
100
Issue
4
Pages
1544-1550
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2036894778
Cited by
20
References
44
Citations by year
2026: 2 · 2025: 2 · 2023: 2 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 1 · 2016: 6 · 2015: 2
FWCI
2.61
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • UWA Profiles and Research Repository (UWA) (submittedVersion, other-oa)
  • Swinburne figshare (Swinburne University of Technology) (submittedVersion)
Funders
  • Pfizer
  • Diabetes Australia
  • Monash University
  • State Government of Victoria
  • Servier
  • Allergan
  • Merck Sharp and Dohme
  • National Health and Medical Research Council
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
Keywords
insulin clearance, insulin sensitivity, metabolic syndrome, obesity, sympathetic activity, norepinephrine spillover, augmentation index, cardiac output, sex differences
MeSH terms
Arteries, Blood Glucose, Cross-Sectional Studies, Female, Glucose Tolerance Test, Humans, Insulin, Insulin Resistance, Male, Middle Aged, Norepinephrine, Obesity, Glucose Clamp Technique, Cohort Studies, Metabolic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review